Artivion, Inc. (NYSE: AORT) is a Healthcare company (Medical - Devices) with a market capitalization of $891M. The Maz Rating grades it against the other companies in its sector.
Artivion, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $18.27, Artivion, Inc. trades at 1.8x sales and 2.0x book value, with an EV/EBITDA of 29.8. Over the last twelve months it generated about $483M of revenue and a net loss of $18M. It runs a gross margin of 61.8%, an operating margin of 1.9% and a net margin of -3.7%. It shows return on equity of -3.9%, return on invested capital of 1.0% and a free cash flow yield of -4.9%. On the balance sheet: a debt-to-equity ratio of 0.91 and a current ratio of 4.42. Over the past 52 weeks the share price ranged from $18.11 to $48.25, with a beta of 1.28.
Artivion, Inc. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 10 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.